The company’s revenue also jumped 5.2 percent from $151.7 million in 2012 to $159.5 million this past quarter.
Nuvasive also announced a partial settlement in the patent litigation with Medtronic. Nuvasive will pay $7.5 million to settle phase II of the litigation. The settlement resolves all disputes related to cervical plate patents and gives NuVasive broad access to Medtronic’s portfolio of cervical plate patents, according to the release.
More Articles on Supply Chain:
20 News Updates for Orthopedic & Spine Device Companies
Alphatec Spine Gross Profits Increase 2.9% in Q1
Device Start-Up NovoSource Receives FDA Clearance for Knee Implant
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
